Active Recombinant Mouse Pcsk9 protein, His-tagged
Cat.No. : | Pcsk9-259M |
Product Overview : | Recombinant Mouse Pcsk9(pro domain: Gln35-Gln155; mature form: Ser156-Gln694) fused with His tag at C-terminal was expressed in NS0. |
- Specification
- Gene Information
- Related Products
Description : | PCSK9 (proprotein convertase subtilisin kexin 9), also known as NARC-1, is a member of the proteinase K subfamily of subtilisin-related serine endoproteases. It is highly expressed in the liver, intestine, and kidney and plays an important role in regulating LDL R expression and circulating cholesterol levels. PCSK9 is synthesized as precursor protein that is autocatalytically cleaved in the endoplasmic reticulum to generate a 14 kDa prodomain and a 60 kDa catalytic domain. Within the secretion pathway, the prodomain remains associated with and functions as a chaperone for the catalytic domain. Mouse PCSK9 shares 78% and 93% amino acid identity with human and rat PCSK9, respectively. PCSK9 plays a key role in the regulation of cholesterol metabolism by binding to hepatic LDL R, LRP-1, VLDL R, and Apolipoprotein E R2 and promoting their lysosomal degradation instead of recycling to the plasma membrane. It can also regulate cholesterol and triglyceride handling in the intestine and adipose tissue. The ability of PCSK9 to regulate LDL R expression is inhibited by its binding to LDL particles or Annexin A2 or by additional proteolytic cleavage. |
Source : | Mammalian cells |
Species : | Mouse |
Tag : | His |
Predicted N Terminal : | Ser156 (mature form); No results obtained for pro domain, Gln35 inferred from enzymatic pyroglutamate treatment revealing Asp36 |
Form : | Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol. |
Bio-activity : | Measured by its binding ability in a functional ELISA. When Recombinant Mouse LDLR is coated at 2 µg/mL, Recombinant Mouse Proprotein Convertase 9/PCSK9 binds with an ED50 = 25-150 ng/mL. |
Molecular Mass : | Predicted Molecular Mass: 14 (pro domain) and 59 (mature form) kDa SDS-PAGE: 18 kDa (pro domain) and 57-67 kDa (mature form), reducing conditions |
Endotoxin : | <0.1 EU per 1 μg of the protein by the LAL method. |
Purity : | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Storage : | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 centigrade as supplied. 3 months, -20 to -70 centigrade under sterile conditions after opening. |
Gene Name : | Pcsk9 proprotein convertase subtilisin/kexin type 9 [ Mus musculus ] |
Official Symbol : | Pcsk9 |
Synonyms : | PCSK9; proprotein convertase subtilisin/kexin type 9; NARC-1; convertase subtilisin; proprotein convertase 9; proprotein convertase PC9; subtilisin/kexin-like protease PC9; neural apoptosis regulated convertase 1; neural apoptosis-regulated convertase 1; FH3; PC9; Narc1; HCHOLA3; AI415265; AI747682; MGC47409; |
Gene ID : | 100102 |
mRNA Refseq : | NM_153565 |
Protein Refseq : | NP_705793 |
Products Types
◆ Recombinant Protein | ||
PCSK9-406C | Recombinant Chinese hamster PCSK9 Protein, His-tagged | +Inquiry |
PCSK9-1257R | Acitve Recombinant Rat PCSK9 protein(Met1-Gln691), His-tagged | +Inquiry |
PCSK9-407H | Recombinant Human PCSK9 Protein, His-tagged | +Inquiry |
PCSK9-035H | Recombinant Human PCSK9 Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
PCSK9-135H | Recombinant Human PCSK9 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
PCSK9-2775RCL | Recombinant Rhesus PCSK9 cell lysate | +Inquiry |
PCSK9-2306RCL | Recombinant Rat PCSK9 cell lysate | +Inquiry |
PCSK9-2564MCL | Recombinant Mouse PCSK9 cell lysate | +Inquiry |
◆ Assay kits | ||
Kit-1808 | PCSK9-LDLR TR-FRET Assay Kit | +Inquiry |
Kit-1806 | PCSK9(D374T)-LDLR TR-FRET Assay Kit | +Inquiry |
Kit-1807 | PCSK9[Biotinylated]-LDLR Binding Assay Kit | +Inquiry |
Kit-0665 | PCSK9-BIRC2 in vitro Binding Assay Kit | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionYes, some studies suggest that mutations in the PCSK9 protein gene may increase the risk of cardiovascular disease. For example, some PCSK9 mutations can cause their dysfunction, resulting in hypercholesterolemia and cardiovascular disease.
PCSK9 protein is combined with immune adjuvants to make a vaccine, or mutated PCSK9 protein to induce an immune response to it, inhibit PCSK9 expression in vivo, increase LDLR levels and reduce serum cholesterol levels.
This protein may have a regulatory effect on weight and obesity, and it is associated with glucose and endocannabinin homeostasis studies have linked PCSK9 to the development of obesity and diabetes.
Several new anti-PCSK9 drugs are already being studied and developed, including oral drugs and gene chromosome therapies, and some drugs have advanced to early stages of clinical trials, providing new options for the treatment of PCSK9 proteins.
Currently on the market to inhibit PCSK9 protein drugs include alirocumab and evolocumab.
PCSK9 protein can degrade LDLR protein, so its overexpression will lead to a decrease in LDLR's ability to be cleared, leading to hypercholesterolemia.
Customer Reviews (3)
Write a reviewIn immunological experiments, it was found that it had good antigenicity and could induce target immune responses.
It promoted cell growth and proliferation.
High catalytic efficiency.
Ask a Question for All Pcsk9 Products
Required fields are marked with *
My Review for All Pcsk9 Products
Required fields are marked with *
Inquiry Basket